» Articles » PMID: 18354393

Pharmacologically Induced Hypogonadism and Sexual Function in Healthy Young Women and Men

Overview
Date 2008 Mar 21
PMID 18354393
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Studies fail to find uniform effects of age-related or induced hypogonadism on human sexual function. We examined the effects of induced hypogonadism on sexual function in healthy men and women and attempted to identify predictors of the sexual response to induced hypogonadism or hormone addback. The study design used was a double-blind, controlled, crossover (self-as-own control). The study setting was an ambulatory care clinic in a research hospital, and the participants were 20 men (average+/-SD age=28.5+/-6.2 years) and 20 women (average+/-SD age=33.5+/-8.7 years), all healthy and with no history of psychiatric illness. A multidimensional scale assessing several domains of sexual function was the main outcome measure. Participants of the study received depot leuprolide acetate (Lupron) every 4 weeks for 3 months (men) or 5 months (women). After the first month of Lupron alone, men received (in addition to Lupron) testosterone enanthate (200 mg intramuscularly) or placebo every 2 weeks for 1 month each. Women received Lupron alone for 2 months, and then, in addition to Lupron, they received estradiol and progesterone for 5 weeks each. The results of the study: in women, hypogonadism resulted in a significant decrease in global measures of sexual functioning, principally reflecting a significant decrease in the reported quality of orgasm. In men, hypogonadism resulted in significant reductions in all measured domains of sexual function. Testosterone restored sexual functioning scores in men to those seen at baseline, whereas neither estradiol nor progesterone significantly improved the reduced sexual functioning associated with hypogonadism in women. Induced hypogonadism decreased sexual function in a similar number of men and women. No predictors of response were identified except for levels of sexual function at baseline. In conclusion, our data do not support a simple deficiency model for the role of gonadal steroids in human sexual function; moreover, while variable, the role of testosterone in sexual function in men is more apparent than that of estradiol or progesterone in women.

Citing Articles

Seminal vesicles - an overlooked pair of accessory glands in male sexual dysfunction: a narrative review.

Gao D, Li C, Jin Y, Sun D, Cui Y, Chen W Int J Impot Res. 2024; .

PMID: 39702662 DOI: 10.1038/s41443-024-01011-4.


Individual Differences in Testosterone and Self-Control Predict Compulsive Sexual Behavior Proneness in Young Males.

Rodriguez-Nieto G, Dewitte M, Sack A, Schuhmann T Front Psychol. 2021; 12:723449.

PMID: 34925132 PMC: 8677662. DOI: 10.3389/fpsyg.2021.723449.


Modeling Human Sexual Motivation in Rodents: Some Caveats.

Le Moene O, Agmo A Front Behav Neurosci. 2019; 13:187.

PMID: 31507386 PMC: 6719563. DOI: 10.3389/fnbeh.2019.00187.


Androgen Deprivation Alters Attention to Sexually Provocative Visual Stimuli in Elderly Men.

Palmer-Hague J, Tsang V, Skead C, Wassersug R, Nasiopoulos E, Kingstone A Sex Med. 2017; 5(4):e245-e254.

PMID: 29150010 PMC: 5693430. DOI: 10.1016/j.esxm.2017.10.001.


The Effect of Targeted Therapy for Genitourinary Malignancies on Sexual Function and Fertility.

Holland B, Shetty Z, Alanee S Curr Urol Rep. 2017; 18(8):65.

PMID: 28712040 DOI: 10.1007/s11934-017-0704-9.


References
1.
Rabkin J, McElhiney M, Rabkin R, McGrath P, Ferrando S . Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. Am J Psychiatry. 2006; 163(1):59-66. DOI: 10.1176/appi.ajp.163.1.59. View

2.
Kwan M, Greenleaf W, Mann J, Crapo L, Davidson J . The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men. J Clin Endocrinol Metab. 1983; 57(3):557-62. DOI: 10.1210/jcem-57-3-557. View

3.
Cawood E, Bancroft J . Steroid hormones, the menopause, sexuality and well-being of women. Psychol Med. 1996; 26(5):925-36. DOI: 10.1017/s0033291700035261. View

4.
Schmidt P, Berlin K, Danaceau M, Neeren A, Haq N, Roca C . The effects of pharmacologically induced hypogonadism on mood in healthy men. Arch Gen Psychiatry. 2004; 61(10):997-1004. DOI: 10.1001/archpsyc.61.10.997. View

5.
Steidle C, Schwartz S, Jacoby K, Sebree T, Smith T, Bachand R . AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab. 2003; 88(6):2673-81. DOI: 10.1210/jc.2002-021058. View